T/CACM 062-2018 Active Group standards

T/CACM 062-2018 The clinical diagnostic criteria for atherosclerotic heart disease with phlegm-stagnation and blood stasis syndrome

T/CACM 062-2018 The clinical diagnostic criteria for atherosclerotic heart disease with phlegm-stagnation and blood stasis syndrome

Publish Date: 2018-06-25 Implement Date: 2018-06-25 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us
Price: $ 20.00
Out of stock

Basic Information

Standard Code: T/CACM 062-2018
Standard Type: Group standards
Standard Status: Active
is_force_gb: no
CCS Name: Medicine
ICS Name: Integrated medical science and healthcare devices
Publish Date: 2018-06-25
Implement Date: 2018-06-25

Scope

Main technical content: According to the "China Cardiovascular Disease Report 2017", cardiovascular disease accounts for more than 40% of all deaths from diseases in China, ranking first among the causes of death for urban and rural residents, and the prevalence and mortality rates of cardiovascular disease are still on the rise [1]. As a common cardiovascular disease, there are 11 million patients with coronary atherosclerotic heart disease (coronary artery disease, hereinafter referred to as CHD). According to the "China Health and Family Planning Statistical Yearbook (2017)" [2], the mortality rate of CHD in China reached 113.46/100,000, and has continued to rise since 2012. With the acceleration of social aging and urbanization, and the prevalence of unhealthy lifestyles among residents, phlegm-stasis syndrome has become one of the main syndromes of CHD. According to reports, the proportion of phlegm-stasis syndrome in CHD patients currently reaches 26.22% [3]. However, there are problems such as "inconsistent diagnostic standards, lack of standardized terminology, and missing diagnostic weights for diagnostic criteria" in previous CHD phlegm-stasis syndrome diagnostic standards, which have affected their application in clinical practice and scientific research. To implement the important task of "comprehensively promoting the construction of a standardized system for traditional Chinese medicine" proposed in the "Medium- and Long-Term Development Plan for the Standardization of Traditional Chinese Medicine (2011-2020)", and to give full play to the advantages of traditional Chinese medicine in the prevention and treatment of cardiovascular diseases, this standard, based on a systematic review of previous CHD phlegm-stasis syndrome diagnostic standards [4-43] (Table A.1 in Appendix A), comprehensively uses methods such as literature systematic review, Delphi method, analytic hierarchy process (AHP), diagnostic test, and qualitative interviews, combined with mult

Development Information

Related Standards

Contact Us